← Leaderboards
Sylvia T Singer
University Of California San Francisco
$2,056,881
Attributed
$5,961,998
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,961,998 · 4
By mechanism
R33$5,206,823 · 1
K23$722,655 · 1
M01$32,520 · 2
Top collaborators
- Douglas V Faller3 shared
- Kevin Kuo3 shared
- Susan P Perrine3 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Elliott P Vichinsky$12,339,152
- Yuet W Kan$9,706,494
- James H. McKerrow$11,473,832
- Ann V Schwartz$6,324,258
- Philip Jon Rosenthal$36,168,903
Others in their field
Top investigators on “Thalassemia”
- Leonard I Zon · Children'S Hospital Boston$15,590,743
- Stuart H Orkin · Children'S Hospital Boston$15,494,749
- Mitchell J Weiss · Children'S Hospital Of Philadelphia$13,173,528
- Stefano Rivella · Weill Medical College Of Cornell Univ$10,978,618
- Mark Thomas Gladwin · Clinical Center$10,973,059
- Gary M Brittenham · Weill Medical Coll Of Cornell Univ$9,600,744
Research focus
ThalassemiaHematological DiseaseClinical TrialsThalassemia IntermediaPathologic ProcessGeneticClinical ResearchHuman SubjectBeta ThalassemiaPhenotypeMedical ComplicationChild (0-11)GenotypeCanadaBlood VesselsBaseBlood PlateletsBiochemicalAspirinAmino AcidsCoagulantsBilirubinCoagulation ProcessClinical Investigator
Grant awards (14)
Development of a Clinical Hemoglobin Modulator$1,630,002
R33 · FY2022 · HL
Development of a Clinical Hemoglobin Modulator$1,843,809
R33 · FY2021 · HL
Development of a Clinical Hemoglobin Modulator$1,733,012
R33 · FY2020 · HL
Pulmonary Hypertension in Thalassemia$144,531
K23 · FY2009 · HL · contact PI
Pulmonary Hypertension in Thalassemia$144,531
K23 · FY2008 · HL · contact PI
Pulmonary Hypertension in Thalassemia$144,531
K23 · FY2007 · HL · contact PI
Pulmonary Hypertension in Thalassemia$144,531
K23 · FY2006 · HL · contact PI
Pulmonary Hypertension in Thalassemia$144,531
K23 · FY2005 · HL
DARBEPOETIN$15,063
M01 · FY2005 · RR
HEMOGLOBIN E/B THALASSEMIA: NATURAL HISTORY &RESPONSE TO CHEMOTHERAPY$0
M01 · FY2002 · RR
HEMOGLOBIN E/B THALASSEMIA: NATURAL HISTORY &RESPONSE TO CHEMOTHERAPY$0
M01 · FY2001 · RR
HEMOGLOBIN E/B THALASSEMIA: NATURAL HISTORY &RESPONSE TO CHEMOTHERAPY$17,457
M01 · FY2000 · RR
HEMOGLOBIN E/B THALASSEMIA: NATURAL HISTORY &RESPONSE TO CHEMOTHERAPY$0
M01 · FY2000 · RR
HEMOGLOBIN E/B THALASSEMIA: NATURAL HISTORY &RESPONSE TO CHEMOTHERAPY$0
M01 · FY2000 · RR